Final Answer:
The adverse effect that the nurse should report in a client receiving gentamicin IV is Tinnitus and hearing loss. Thus option B is correct.
Step-by-step explanation:
Gentamicin, an aminoglycoside antibiotic, is associated with various adverse effects. Tinnitus and hearing loss are particularly significant and should be reported promptly due to their potential for irreversible damage. Gentamicin can cause ototoxicity, affecting the vestibular and auditory systems. The inner ear's sensory hair cells can be damaged by the accumulation of gentamicin, leading to auditory and vestibular dysfunction.
Tinnitus, characterized by ringing or buzzing in the ears, often precedes hearing loss and serves as an early warning sign of ototoxicity. Hearing loss, typically starting with high-frequency sounds, can progress to affect speech perception and daily functioning. It's crucial for the nurse to recognize these symptoms as signs of potential harm to the client's hearing and immediately notify the healthcare provider to assess and potentially adjust the medication regimen.
Regular monitoring of the client's auditory function, including audiograms, and assessing for symptoms like tinnitus or hearing changes are essential preventive measures. Gentamicin dosage is often adjusted based on therapeutic drug monitoring, where the drug's serum levels are measured to ensure efficacy while avoiding toxicity. Prompt reporting and close monitoring of these adverse effects can help prevent irreversible damage and ensure appropriate management for the client. Thus option B is correct.